BioMarin Pharmaceutical, Inc. (BMRN)
58.99
-1.05
(-1.75%)
USD |
NASDAQ |
Dec 30, 16:00
58.00
-0.99
(-1.68%)
After-Hours: 20:00
BioMarin Pharmaceutical Market Cap: 11.33B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.397B |
| Gilead Sciences, Inc. | 152.83B |
| Merck & Co., Inc. | 263.24B |
| AbbVie, Inc. | 406.04B |
| Bristol Myers Squibb Co. | 110.36B |
Market Cap Related Metrics
| PE Ratio | 22.10 |
| PS Ratio | 3.739 |
| PEG Ratio | 0.3641 |
| Price to Book Value | 1.871 |
| Price to Free Cash Flow | 13.97 |
| Price | 58.99 |
| Earnings Yield | 4.52% |
| PEGY Ratio | 0.3641 |
| Operating PE Ratio | 13.48 |
| Normalized PE Ratio | 16.53 |